Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Improving Pain Management with Pharmacogenomics: A General Introduction.

Journal of pain & palliative care pharmacotherapy - 1 Sept 2020

Schuh Michael J, Randles Heather, Crosby Sheena

Abstract excerpt

Tailoring an individual patient's pain treatment is paramount to decreasing patient suffering and diminishing morbidity. Performing pharmacogenomic (PGx) testing can help guide prescribing decisions for current and future medication therapy by assisting dosage adjustments to increase therapeutic efficacy, decrease adverse drug reactions and avoid potentially ineffective medications. Pharmacogenomics is the study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytochrome P-450 Enzyme System
Share to Drug-Related Side Effects and Adverse Reactions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Variation

Share to Pain Management

Share to Pharmacogenetics

Share to Pharmacogenomic Variants

Share to Precision Medicine

Source

Identifiers

PMID: 32186418
DOI: 10.1080/15360288.2020.1734140

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Improving Pain Management with Pharmacogenomics: A General Introduction.PMID 32186418Read ↗

Individualized Management of Osteoarthritis: The Role of Pharmacogenomics to Optimize Pain TherapySemantic proximity Read ↗

Pain management in the 21st century: utilization of pharmacogenomics and therapeutic drug monitoring.Semantic proximity Read ↗

What is the future of pharmacogenomics in pain management?Semantic proximity Read ↗

The value of CYP2D6 and OPRM1 pharmacogenetic testing for opioid therapy.Semantic proximity Read ↗

A Review of the Role of Genetic Testing in Pain MedicineSemantic proximity Read ↗

Pharmacogenomic considerations in the opioid management of painSemantic proximity Read ↗

Review of Opioid Pharmacogenetics and Considerations for Pain ManagementSemantic proximity Read ↗

A systematic review of pharmacogenetic guided opioid therapy for pain.Semantic proximity Read ↗

Evidence Regarding Pharmacogenetics in Pain Management and Cancer.Semantic proximity Read ↗

Fundamental Considerations for GeneticallyGuided Pain Management with Opioids Based on CYP2D6 and OPRM1 PolymorphismsSemantic proximity Read ↗

The Role of Clinical Pharmacogenetics and Opioid Interactions in Optimizing Treatment in Clinical PracticeSemantic proximity Read ↗

Pain and genetics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.